Method development, validation, and stability studies of teneligliptin by RP-HPLC and identification of degradation products by UPLC tandem mass spectroscopy [PDF]
A Halabi +7 more
core +1 more source
A retrospective study of seasonal variation in sodium-glucose co-transporter 2 inhibitor-related adverse events using the Japanese adverse drug event report database. [PDF]
Matsumoto K +16 more
europepmc +1 more source
Drug-induced tubulointerstitial nephritis in a retrospective study using spontaneous reporting system database. [PDF]
Oyama S +7 more
europepmc +1 more source
Association between chronic diseases and severe periodontal disease progression: A retrospective cohort study in a city of Japan. [PDF]
Nin S +8 more
europepmc +1 more source
Nitroxoline induces cell apoptosis by inducing MDM2 degradation in small-cell lung cancer. [PDF]
Yu JG, Ji CH, Shi MH.
europepmc +1 more source
Quality by Design Tool Assessed Ultraperformance Liquid Chromatography Method for the Analysis of Remogliflozin and Teneligliptin in Oral Dosage Form. [PDF]
Menda J +5 more
europepmc +1 more source
Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes. [PDF]
Kishimoto M.
europepmc +1 more source
Concomitant pyogenic spondylodiscitis and empyema following tongue cancer resection and wisdom tooth extraction: A case report and literature review. [PDF]
Yoshizawa K +5 more
europepmc +1 more source
Related searches:
RP-HPLC stability indicating specific, precise, accurate, cost-effective and isocratic method was developed and validated for quantitative analysis of Atorvastatin calcium and Teneligliptin hydrobromide hydrate in synthetic mixture with presence of its ...
Urvi J. Chotaliya +4 more
semanticscholar +4 more sources
ABSTRACT Most people with diabetes mellitus type 2 require more than one antihyperglycemic medication to achieve glycemic control. Products comprising one or more active components are utilized for certain indications. Several benefits, including impending therapeutic efficacy, fewer adverse drug effects, pharmacokinetic advantages ...
Himani Acharya, Rajendra Kotadiya
semanticscholar +4 more sources

